AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 284: H71-H80, 2003. First published August 29, 2002; doi:10.1152/ajpheart.00392.2002
0363-6135/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/1/H71    most recent
00392.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, X.
Right arrow Articles by Rasmusson, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, X.
Right arrow Articles by Rasmusson, R. L.
Vol. 284, Issue 1, H71-H80, January 2003

Regulation of N- and C-type inactivation of Kv1.4 by pHo and K+: evidence for transmembrane communication

Xiaoyan Li1,2, Glenna C. L. Bett1, Xuejun Jiang1, Vladimir E. Bondarenko1, Michael J. Morales1, and Randall L. Rasmusson1

1 Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York 14214-3005; and 2 Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China 430060


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Kv1.4 encodes a slowly recovering transient outward current (Ito), which inactivates by a fast N-type (intracellular ball and chain) mechanism but has slow recovery due to C-type inactivation. C-type inactivation of the NH2-terminal deletion mutant (fKv1.4Delta N) was inhibited by 98 mM extracellular K+ concentration ([K+]o), whereas N-type was unaffected. In 98 mM [K+]o, removal of intracellular K+ concentration ([K+]i) speeded C-type inactivation but had no effect on N-type inactivation, suggesting that C-type inactivation is sensitive to K+ binding to intracellular sites. C-type inactivation is thought to involve closure of the extracellular pore mouth. However, a valine to alanine mutation on the intracellular side of S6 (V561A) of fKv1.4Delta N alters recovery and results in anomalous speeding of C-type inactivation with increasing [K+]o. Extracellular pH (pHo) modulated both N- and C-type inactivation through an S5-H5 linker histidine (H508) with acidosis speeding both N- and C-type inactivation. Mutation of an extracellular lysine to a tyrosine (K532Y) slowed C-type inactivation and inhibited the pH dependence of both N- and C-type inactivation. These results suggest that mutations, [K+], and pH modulate inactivation through membrane-spanning mechanisms involving S6.

voltage-gated channel; ion; Kv1.1; ataxia


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

A RAPIDLY INACTIVATING K+ channel is Kv1.4, which is thought to form the molecular basis for a rapidly inactivating, slowly recovering, transient outward current in the endocardium of several mammalian species, including humans (3). Its expression is upregulated in the mammalian endocardium during hypertrophy and heart failure (15, 26, 27, 34). Understanding the inactivation and recovery mechanisms of this channel is critical to understanding the ionic dependence, response to acidosis and alkalosis, drug affinity, and use-dependent drug-binding properties (38, 44). Kv1.4 inactivates by two well-established processes: N- and C-type inactivation. N-type inactivation is fairly well characterized and results from the occlusion of the intracellular side of the pore by a "ball and chain" mechanism formed by the NH2 terminus of the channel molecule (20, 21, 24, 25, 32, 49). C-type inactivation is not so well understood but appears to involve conformational changes on the extracellular side of the pore (29) because it is sensitive to extracellular permeant ions (22, 31, 38), extracellular tetraethylammonium (2, 7, 22, 28), and mutations near the extracellular mouth of the channel (6, 14, 40). C-type inactivation is thought to be closely related to the "slow" inactivation mechanisms observed in calcium and sodium channels. Despite their different molecular bases, these mechanisms are coupled (21): C-type inactivation is more rapid in the presence of N-type inactivation (4). Recovery from inactivation is controlled by the slower C-type mechanism (37), making it physiologically important.

Two nonmutually exclusive mechanisms have been proposed to explain the coupling between N-type inactivation, an intracellular event (20, 21, 25, 32, 49), and C-type inactivation (29, 31, 36), an extracellular event. The Permeation Hypothesis is based on the fact that movement of K+ through the pore can result in a localized extracellular K+ concentration ([K+]o) accumulation (4). These ions can bind to an extracellular site and thus slow C-type inactivation. Coupling occurs when the NH2 terminus of the channel blocks the flow of K+, dissipating the [K+]o accumulation and increasing C-type inactivation (4). An alternative proposal for N- and C-type inactivation coupling is the Allosteric Hypothesis, in which the NH2-terminal binding during N-type inactivation stabilizes the transmembrane segments of the channel into a conformation that promotes the development of C-type inactivation (37, 38). The Allosteric Hypothesis still allows for modulation of inactivation by [K+]o via an extracellular binding site, but this is not the way in which the two inactivation processes are linked.

In this study, we demonstrate that even though N- and C-type inactivation is associated with intracellular and extracellular events, respectively, they are both strongly influenced by events occurring at pore sites physically distant from their major site of action. These global conformational changes are responsible for the pH and [K+]o dependency of N- and C-type inactivation. They suggest an important physiological role for allosteric coupling between the intracellular and extracellular domains of the Kv1.4 channel.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Mature female Xenopus laevis (Xenopus Express) were cared for by standards approved by the Institutional Animal Care and Use Committee of the University at Buffalo State University of New York. Frogs were anesthetized by immersion in tricaine solution (1 g/l; Sigma). Oocytes were digested by placing them in a collagenase-containing, Ca2+-free OR2 solution (in mM: 82.5 NaCl, 2 KCl, 1 MgCl2, and 5 HEPES; pH 7.4, 1 mg/ml collagenase, type I; Sigma). The oocytes were gently shaken for 1.5-2 h, with the enzyme solution refreshed at 1 h. Defolliculated oocytes (stages V-VI) were injected with up to 50 ng mRNA for a Kv1.4 channel clone originally isolated from ferret heart (9) by using the Nanoject microinjection system (Drummond Scientific; Broomall, PA). Oocytes were voltage clamped by using a two-microelectrode oocyte clamp amplifier (CA-1B, Dagan; Minneapolis, MN), and currents were recorded at room temperature. Microelectrodes with resistances of 0.5- 1.5 MOmega were fabricated from 1.5-mm outer diamter borosilicate glass tubing (TW150-4, WPI) with the use of a two-stage puller and filled with 3 M KCl. The control extracellular solution (ND-96) contained (in mM) 96 NaCl, 2 KCl, 1 MgCl2, 1.8 CaCl2, and 10 HEPES; pH adjusted to 7.4. The 98 mM K+ solution contained (in mM) 98 KCl, 1 MgCl2, 1.8 CaCl2, and 10 HEPES; pH 7.4.

Giant torn-off patches (17) were taken from some oocytes and used as inside-out membrane patches in which intracellular solutions were controlled by a rapid solution switching device (ALA Scientific Instruments). Microelectrodes (0.5 MOmega ) were coated with a mixture containing 5% parafilm and light mineral oil. The giant patch electrode solution contained (in mM) 98 KCl, 1 MgCl2, 2.5 CaCl2, and 10 HEPES; pH adjusted to 7.4. For giant-patch experiments, the initial bath solution was (in mM) 98 KCl, 1.8 MgCl2, 1 EGTA, and 10 HEPES; pH adjusted to7.4. Giant patch currents sizes measured at +50 mV were 7.6 ± 7.1 nA in normal intracellular solution and -1.02 ± 0.78 nA in K+-free intracellular solution for fKv1.4 (means ± SD, n = 5) and 1.49 ± 1.29 nA in normal intracellular solution and -0.16 ± 0.14 nA in K+-free intracellular solution for fKv1.4Delta N (means ± SD, n = 6)

Data were digitized and analyzed by using pCLAMP (Axon Instruments). Further analysis was performed by using Clampfit (Axon Instruments), Excel (Microsoft), and Origin (Microcal Software). Data were filtered at 2 kHz. Data are shown as means ± SE. Confidence levels were calculated using Student's paired t-test.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

High [K+]o reduces the C-type inactivation rate (31), an observation that led to the "Foot-in-the-Door" Hypothesis (2), and subsequently the Permeation Hypothesis of coupling between N- and C-type inactivation (4). A prediction of the Permeation Hypothesis is that in the presence of saturating concentrations of [K+]o, C-type inactivation should be insensitive to the intracellular K+ concentration ([K+]i).

This prediction can be tested directly in torn-off giant patches (17) from Xenopus oocytes expressing ferret Kv1.4Delta N [amino acids 2-146 are deleted (9)] channels, which lack N-type inactivation but show robust C-type inactivation. Contrary to the prediction of the Permeation Hypothesis, in the presence of saturating (98 mM) levels of [K+]o removing [K+]i and replacing it with 98 mM N-methyl-D-glutamic acid increased the rate of inactivation (Fig. 1). This demonstrates that [K+]o is not the only coupling pathway between N- and C-type inactivation. Furthermore, this suggests that intracellular interactions have an effect on the extracellular conformation of the channel, which is consistent with the Allosteric but not the Permeation Hypothesis.


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 1.   Intracellular ion substitution changes the rate of C-type but not N-type inactivation. We used the giant excised patch voltage-clamp technique to control solutions on both side of oocyte membranes expressing ferret Kv1.4 channels. Intracellular K+ concentration ([K+]i) (98 mM) was replaced with equimolar N-methyl-D-glucamine (NMDG). Oocytes patches were held at -90 mV and stepped to +50 mV. A: replacement of [K+]i with NMDG had no effect on N-type inactivation on normalized currents from wild-type fKv1.4 channels. In 98 mM [K+]itau inactivation = 38.34 ± 6.48 ms and in 98 mM intracellular NMDG+ ([NMDG+]i) and tau inactivation = 44.69 ± 3.81 ms (n = 5, P < 0.05). B: C-type inactivation of normalized currents of an NH2-terminal deletion mutant (amino acids 2-146) of fKv1.4. In 98 mM [K+]itau inactivation = 0.84 ± 0.11 s compared with 0.55 ± 0.09 s in 98 mM [NMDG+]i (n = 6, P < 0.01).

The Allosteric Hypothesis proposes that the channel can adopt different conformations with different likelihoods of entering the C-type inactivated state. It therefore predicts that certain mutations on the intracellular side of the channel will alter the properties of C-type inactivation (37). Mutations near the extracellular mouth of the pore that affect C-type inactivation are well known; however, there have been few reports on intracellular mutations with similar effects on C-type inactivation. One intracellular change that does alter C-type inactivation is a spontaneous mutation in human Kv1.1 channels, which causes episodic ataxia (1). This mutation occurs at the extreme intracellular mouth of the pore on S6 and involves a valine to alanine substitution. We examined this mutation at an equivalent position in our Kv1.4 NH2-terminal deletion mutant: fKv1.4[V561A]Delta N (Fig. 2).


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 2.   A: representation of mutant fKv1.4 constructs employed in this study. Schematic representation of the topology of a single fKv1.4 alpha -subunit is shown. In many of the experiments in this study the NH2-terminal domain (amino acids 2-146) was deleted to allow us to study the slower C-type inactivation mechanism. The amino acid sequences of the H5 and S6 region are shown. Constructs used in this study involve mutation of the histidine at position 508, the lysine at 532, and the valine at 561. See Fig. 7 for a three-dimensional representation of the channel and mutations. B: inactivation of fKv1.4Delta N expressed in Xenopus oocytes recorded by using a two-electrode voltage clamp. Oocytes were held at -90 mV and then were clamped first for 5 s to a potential (P1) between -90 to +50 mV in 10-mV steps then stepped to a potential (P2) of + 40 mV for 1 s. C: currents recorded from fKv1.4[V561A]Delta N. Under these experimental conditions (2 mM [K+]o) no significant differences were seen in the time course of C-type inactivation.

Previous studies in Kv1.1 channels showed that the steady-state properties of C-type inactivation were unaffected by this mutation but inactivation was significantly faster (1). Under control conditions with 2 mM [K+]o (to mimic amphibian extracellular fluid composition), we observed no difference in the rate of C-type inactivation between fKv1.4Delta N and fKv1.4[V561A]Delta N (Fig. 2, B and C). The apparent lack of a fKv1.4[V561A]Delta N phenotype was unexpected, so we examined this mutant construct more closely. In Kv1.1 the most striking phenotypic change associated with this mutation was a dramatic increase in the rate of recovery from C-type inactivation (1). We examined recovery using a two-pulse protocol (Fig. 3A). Despite the apparent lack of effect on the development of inactivation, fKv1.4[V561A]Delta N exhibited a dramatic increase in the rate of recovery from inactivation in 2 mM [K+]o at +40 mV, a result qualitatively similar to the effect of the analogous mutation in Kv1.1 channels (1).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   A: recovery from inactivation of fKv1.4Delta N and fKv1.4[V561A]Delta N measured with a two-electrode voltage clamp. Oocytes were stepped from -90 to +50 mV for 5 s (P1) and then returned to the holding potential for a variable interval Delta t. The degree of recovery at time Delta t was measured with a second pulse (P2) to +50 mV. Recovery was calculated by comparing the peak current elicited by P2 relative to the peak P1 current and plotting against the interval. Average recovery half-time (t1/2) for fKv1.4Delta N was 1.64 ± 0.25 s (n = 5), and t1/2 for fKv1.4[V561A]Delta N was 0.24 ± 0.04 s (n = 5). Note that recovery in the V561A mutant construct is significantly faster than in the channel with just the NH2-terminal deletion (P < 0.01). B: pseudo-steady-state inactivation relationship for fKv1.4Delta N and fKv1.4[V561A]Delta N. Oocytes were stepped from -90 mV to a potential (P1) between -90 to +50 mV in 10-mV steps followed by a second pulse (P2) to +50 mV for 1 s. The pseudo-steady-state inactivation for each P1 voltage was calculated as the magnitude of the peak current in P2 compared with that from the maximum value of P2 obtained when P1 was -90 mV. [K+]o was 2 mM. Average data are shown as means ± SE (fKv1.4Delta N: V1/2 = -42.26 ± 0.77 mV, k = 0.50 ± 0.01; fKv1.4[V561A]Delta N: V1/2 = -40.51 ± 0.52 mV, k = 0.38 ± 0.01, where V1/2 is the half inactivation voltage and k is the slope factor) (n = 7).

The increase in recovery rate seen in Fig. 3A may be due to differences in the C-type inactivation mechanism in the two channels. Alternatively, because C-type inactivation is coupled to activation (19, 37, 38), the difference could be produced by a shift in the voltage dependence of recovery. Once the channel is sufficiently activated, inactivation proceeds with little or no voltage dependence at positive potentials. For many channels, recovery from inactivation is voltage dependent (18). Recovery is thought to be energetically linked to backward movement of the voltage sensor so that the inactivation recovery rate can be altered if the voltage dependence of inactivation is shifted. Figure 3B shows steady-state inactivation as a function of holding potential for both fKv1.4Delta N and fKv1.4[V561A]Delta N. The valine-to-alanine mutation does not shift the voltage dependence of inactivation. This is in contrast to observations in the related, but not identical, Shaker channel, in which the analogous valine to alanine mutation causes a shift in voltage dependence of steady-state activation and inactivation (5).

Recovery from C-type inactivation, just like development of C-type inactivation, is strongly sensitive to [K+]o (31, 37, 38). We examined the effect of [K+]o on recovery of fKv1.4Delta N and fKv1.4[V561A]Delta N. Switching from 2 to 98 mM [K+]o greatly increased the recovery of fKv1.4Delta N but had a much smaller effect on fKv1.4[V561A]Delta N recovery (Fig. 4, A and B).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 4.   [K+]o dependence of recovery from inactivation in fKv1.4Delta N and fKv1.4[V561A]Delta N channels. Protocol as in Fig. 3A. A: average recovery time course for fKv1.4Delta N in 2 and 98 mM [K+]o. Inset, same data normalized between 0 and 1 and presented with interval as a log scale. t1/2 for fKv1.4Delta N was 1.64 ± 0.25 s in 2 mM [K+]o and t1/2 was 0.29 ± 0.01 s in 98 mM [K+]o (n = 5, P < 0.01). B: average recovery time course for fKv1.4[V561A]Delta N in 2 and 98 mM [K+]o. Inset, same data normalized between 0 and 1 and presented with interval as a log scale. t1/2 for fKv1.4[V561A]Delta N was 0.24 ± 0.04 s in 2 mM [K+]o, and t1/2 was 0.11 ± 0.02 s in 98 mM [K+]o (n = 5, P < 0.01). Note that recovery in the V561A mutant construct is less sensitive to [K+]o than fKv1.4Delta N. For both channels, current recordings were obtained under two electrode voltage-clamp conditions (same protocols as Fig. 3). Average data shown as means ± SE. C: inactivation of fKv1.4Delta N is slower when [K+]o is switched from 2 to 98 mM. Same protocol was used in as Fig. 2, i.e., a 5-s pulse was applied but only the current from first 1.5 s of the pulse is shown. Traces show inactivation in response to a depolarization from -90 mV to +50 mV from the same oocyte. Note that the rate and degree of C-type inactivation is diminished by increasing [K+]o. Currents were normalized to compensate for changes in reversal potential. With 2 mM [K+]o, tau inactivation = 2.70 ± 0.19 s, and with 98 mM [K+]o, tau inactivation = 3.29 ± 0.33 s (n = 7, P < 0.05). Slowing of inactivation by [K+]o is considered one of the defining characteristics of C-type inactivation. D: V561A mutation reverses the [K+]o dependence of C-type inactivation. fKv1.4[V561A]Delta N channels show an abnormal increase in the rate of inactivation when [K+]o is switched from 2 to 98 mM. Note that the rate and degree of C-type inactivation is strongly enhanced by increasing [K+]o. Currents were normalized to compensate for changes in reversal potential. With 2 mM [K+]o, tau inactivation = 2.14 ± 0.19 s, and with 98 mM [K+]o, tau inactivation = 1.38 ± 0.07 s (n = 6, P < 0.01). V561A point mutation results in a reversal in phenotype, which results in a increase in the rate of inactivation with increased [K+]o.

This alteration in recovery rate [K+]o sensitivity suggests that the intracellular V561A mutation may have changed K+ sensitivity at the extracellular site (31, 48). This prompted a reexamination of C-type inactivation at positive potentials in both fKv1.4Delta N and fKv1.4[V561A]Delta N. C-type inactivation of fKv1.4Delta N was slowed by switching from 2 to 98 mM [K+]o, consistent with previous observations (Fig. 4C). However, switching from 2 to 98 mM [K+]o resulted in an increase in C-type inactivation of fKv1.4[V561A]Delta N (Fig. 4D), which is opposite to the effect observed in Kv1.4 and other K+ channels (31, 37, 38). The change in [K+]o affinity suggests a link between the intracellular portion of S6 and K+ binding at the opposite side of the channel and is not predicted by the Permeation Model.

The manipulations presented in Fig. 4 are relatively extreme changes in [K+]o and represent changes measured at only one voltage. To assess the range of [K+]o over which the effect occurs and whether these changes might be significant within the physiological and pathophysiological range of [K+]o, we repeated these experiments on the fKv1.4Delta N and fKv1.4[V561A]Delta N channels at 0.5, 2, 10, 25, and 98 mM [K+]o. The reversal in relationship between [K+]o and C-type inactivation is seen over this entire range (Fig. 5), with inactivation of fKv1.4[V561A]Delta N becoming faster with increasing [K+]o. Both the fKv1.4Delta N and fKv1.4[V561A]Delta N channels retained the voltage-insensitivity characteristic of C-type inactivation rates at positive potentials (37) (Fig. 5B). Although [K+]o has completely opposite effects on the two channels, there is a strong relationship between [K+]o and inactivation time constant for the two constructs. Furthermore, the [K+]o dependence of inactivation rate "crosses over" at 2.0 mM. This suggests that C-type inactivation was directly modified by the mutation. For example, at 0.5 mM fKv1.4[V561A]Delta N inactivation was slower than in fKv1.4Delta N. This is important because it is possible to explain an increase in inactivation rate by mutagenesis inducing an additional inactivation "gate," but a slowing of inactivation requires the point mutation at V561A to have slowed the intrinsic C-type inactivation.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 5.   Reversal of the V561A mutant K+ dependence is observed over a range of values of [K+]o. A: time constants of C-type inactivation (normalized to the value at 2 mM [K+]o) for fKv1.4Delta N and fKv1.4[V561A]Delta N channels at 0.5, 2, 10, 25, and 98 mM [K+]o. For fKv1.4Delta N channels there is a decrease in the rate of C-type inactivation with increasing [K+]o, whereas the inactivation rate of fKv1.4[V561A]Delta N channels increases over the same range. For fKv1.4Delta N, the time constants of inactivation normalized to those at 2 mM [K+]o were for [K+]o = 0.5 mM, tau inactivation = 0.66 ± 0.01; [K+]o = 10 mM, tau inactivation = 1.10 ± 0.01; [K+]o = 25 mM, tau inactivation = 1.19 ± 0.02; and [K+]o = 98 mM, tau inactivation = 1.58 ± 0.01. For fKv1.4[V561A]Delta N, the time constants of inactivation normalized to those at 2 mM [K+]o were for [K+]o = 0.5 mM, tau inactivation = 1.03 ± 0.01; [K+]o = 10 mM, tau inactivation = 0.85 ± 0.01; [K+]o = 25 mM, tau inactivation = 0.76 ± 0.01; and [K+]o = 98 mM, tau inactivation = 0.60 ± 0.04 (n = 3 to 8). B: time constant of C-type inactivation is voltage independent in fKv1.4[V561A]Delta N channels for positive voltages.

Other extracellular factors affect both the N- and C-type inactivation characteristics of fKv1.4 channels. Changes in pHo alter the N-type inactivation in fKv1.4 channels (Fig. 6). Extracellular acidosis increases the rate of N-type inactivation, whereas alkalosis slows the development of N-type inactivation. This pHo dependence suggests that there is some form of transmembrane transduction, for changes in pHo alter the characteristics of NH2-terminal binding at the intracellular face of the channel. A parallel shift in the rate of C-type inactivation is observed in fKv1.4Delta N. This pHo dependence of C-type inactivation occurs roughly in proportion to the changes in N-type inactivation, despite occurring on vastly different time scales.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 6.   Extracellular pH affects the rate of inactivation and recovery from inactivation of fKv1.4 channels measured in oocytes under a two-electrode voltage clamp. A: current traces from fKv1.4 (wt) in response to a depolarizing step from -90 mV to +50 mV at pH 6.8, 7.4, and 8.0. At pHo 6.8, tau inactivation = 44.88 ± 4.91 ms; pH 7.4 tau inactivation = 61.63 ± 7.07 ms; and pH 8.0 tau inactivation = 73.12 ± 6.17 ms (n = 5, P < 0.01). B: current traces from fKv1.4Delta N channels showing the effect of pH with the same protocol as for A. At pH 6.8, tau inactivation = 2.13 ± 0.18 s; pH 7.4 tau inactivation = 2.77 ± 0.18 s; and pH 8.0 tau inactivation = 3.20 ± 0.16 s (n = 6, P < 0.01). The result of changing pH is similar (and of a comparable magnitude) for both channels: acidosis increases and alkalosis slows the rate of inactivation. C: average time course of recovery for fKv1.4 (wt) at pH 6.8, 7.4, and 8.0 using a similar protocol to Fig. 3. Inset: same data normalized between 0 and 1 and presented with interval as a log scale. D: average time course of recovery for fKv1.4Delta N at pH 6.8, 7.4, and 8.0. Inset, same data normalized between 0 and 1, and presented with interval as a log scale.

An important aspect of the relationship between N- and C-type inactivation is that they are coupled. The increase in C-type inactivation of channel with pH might reflect a new conformational transition with altered coupling. Therefore, we examined the effect of pHo on the rate of recovery from N- and C-type inactivation. As was the case for development of N- and C-type inactivation, the rates of recovery from inactivation for both fKv1.4 and fKv1.4Delta N were nearly identical and showed parallel shifts with changes in pHo (Fig. 6). This suggests that pHo-modified C-type inactivation retains the characteristic coupling between N- and C-type inactivation (for a review see Ref. 38) in which N-type inactivation promotes rapid development of C-type inactivation and recovery from both is governed by C-type inactivation.

The pHo dependence of C-type inactivation is modulated by an extracellular histidine at position 508 (8). Mutation of this histidine to a glutamine removes the pHo dependence of N-type inactivation of fKv1.4[H508Q] [normalized to tau inactivation at pH 7.4, tau inactivation at pH 6.8 is 1.07 ± 0.04 and pH 8.0 is 0.99 ± 0.02 (n = 8, P < 0.01)] and C-type inactivation of fKv1.4[H508Q]Delta N [normalized to pH 7.4, tau inactivation at pH 6.8 is 1.05 ± 0.07 and pH 8.0 is 1.03 ± 0.06 (n = 4, P < 0.01), where tau inactivation is the time constant of inactivation]. The C-type nature of this coupling was confirmed using a lysine to tyrosine mutant, fKv1.4[K532Y]Delta N, which inhibits C-type inactivation (8) and abolishes the pHo dependence of both N- and C-type inactivation [normalized to pH 7.4, tau inactivation at pH 6.8 is 0.94 ± 0.02 and pH 8.0 is 0.91 ± 0.03 (n = 5, P < 0.01)]. These results provide further evidence for transmembrane coupling of a mechanism that fulfills the criteria for C-type inactivation.

Finally, we examined the combined effects of pHo and [K+]o on C-type inactivation of fKv1.4[V561A]Delta N. Changing pHo from 7.4 to 6.8 in 2 mM [K+]o results in an increase in the rate of inactivation of fKv1.4[V561A]Delta N [from 2.98 ± 0.08 to 2.51 ± 0.02 s (n = 3, P < 0.05)], which is similar to the effect pHo has on fKv1.4 and fKv1.4Delta N channels (see Fig. 6). The rate of fKv1.4[V561A]Delta N inactivation at pH 6.8 can be further increased by switching [K+]o from 2 to 98 mM [from 2.51 ± 0.02 s to 1.87 ± 0.08 s (n = 4, P < 0.01)]. This demonstrates that the intracellular S6 mutation at V561 results in an alteration in the [K+]o sensitivity independent of the actual kinetic rates of C-type inactivation.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Kv1.4 channels mediate a slowly recovering outward current with upregulated expression during ischemia. Therefore, understanding the molecular basis of the kinetic behavior of Kv1.4 channels in response to changes in pH and [K+] may be of considerable physiological importance. Our data demonstrate that a mutation at an intracellular site on S6 can alter qualitative properties normally associated with the extracellular pore mouth in Kv1.4 channels. Conversely, pHo modulates N-type inactivation, which is a primarily intracellular event. Both [K+]o and pHo determine the recovery from inactivation of this channel in an additive manner through their interactions with C-type inactivation.

Protonation of an extracellular histidine (H508) affected N-type inactivation, an intracellular process. It is unlikely that mobility of the NH2-terminal is altered by manipulating the charge of an extracellular amino acid. Therefore, protons binding to H508 must alter either the availability of the NH2-terminal binding site or the rate of inactivation following NH2-terminal binding. Either way, our data establish a link between the extracellular H508 and conformational changes on intracellular domains associated with inactivation. This is consistent with the relationship between activation and inactivation in voltage-gated channels (19, 38). Cocrystallization of KcsA and a bound NH2-terminal domain (50) suggest that the structure of the bound NH2-terminal domain is significantly different from the NH2-terminal peptide in solution (47), which indicates that binding involves reciprocal rearrangements of the alpha -subunit and the NH2-terminal domain.

The effect of [H+]o on N-type inactivation can be disrupted by mutating the lysine at position 532. Given that the intracellular locus of action of N-type inactivation binding with S6 is well established, it is likely that protonation of H508 communicates with both N- and C-type inactivation through S6.

The molecular basis underlying C-type inactivation is unclear, so it is defined by a mixture of functional attributes. The slow inactivation of Kv1.4 channels fits most of the classical definitions of C-type inactivation. However, a simple point mutation on the intracellular side of S6 changes the phenotype with respect to [K+]o sensitivity. This finding might cause us to conclude that the channel no longer inactivates via a C-type mechanism.

The question of whether fKv1.4[V561A]Delta N exhibits modified C-type inactivation or has introduced or enhanced a second inactivation process is an interesting one. If we consider that fKv1.4[V561A]Delta N introduces a second independent inactivation process, then there will be two inactivation gates with opposite [K+]o dependence. In 2 mM [K+]o, fKv1.4[V561A]Delta N inactivates at the same rate as fKv1.4Delta N. At higher [K+]o, fKv1.4[V561A]Delta N inactivation becomes faster, indicating that the second V561A gate is dominant. However, when [K+]o is below 2 mM [K+]o, the two-gate hypothesis suggests that the inactivation rate would again become faster because the C-type mechanism would be dominant. However, fKv1.4[V561A]Delta N inactivation becomes slower when [K+]o is <2 mM, suggesting that the S6 mutation has modified C-type inactivation rather than introduced a new inactivation mechanism.

This complete reversal of [K+]o dependence is clearly not the result of a simple change in the K+ affinity for an external binding site. No matter how drastically the affinity was altered, there would still be the same qualitative result: an increase in [K+]o would result in a slowing of inactivation. The V561A mutation completely reversed the direction of this relationship, with an increase in [K+]o increasing inactivation. This cannot be explained in terms of the Permeation Model. The anomalous [K+]o dependence of C-type inactivation is strong evidence for allosteric interactions between the intracellular and extracellular faces of the channel.

The intracellular V561 mutation leading to an alteration of phenotype in response to [K+]o manipulations is similar to response of mutated Shaker channels to heavy metal binding. A threonine-to-cysteine mutation (T449C) in the extracellular mouth of the Shaker channel reverses the relationship between extracellular zinc and the rate of C-type inactivation (48).

The pH dependence of inactivation of fKv1.4[V561A]Delta N provides further evidence that the properties of C-type inactivation have been modified. The ability of the K532Y mutation to disrupt pH dependence of Kv1.4 suggests that the pH modulation of inactivation occurs through the C-type inactivation mechanism. fKv1.4[V561A]Delta N shows an increase in the rate of inactivation with acidosis similar to the wild-type channel. Given the similarity in response to acidosis of inactivation of the wild-type and V561A channels, it seems simplest to conclude that fKv1.4[V561A]Delta N alters the properties of C-type inactivation rather than inducing a second inactivation mechanism.

The data in this paper demonstrate transmembrane energetic interactions on gating, which require some degree of change in protein conformation in response to the manipulations. This is particularly apparent in the ability of pHo to modulate both N- and C-type inactivation. It clearly establishes a physiologically relevant role for allosteric interactions associated with C-type inactivation, particularly in determining the role of pH and [K+]o sensitivity, as well as recovery characteristics for coupled N- and C-type inactivation.

The relationship between N-type inactivation and C-type inactivation may have broader implications for members of the Kv1 family. The role of the NH2-terminal domain of the alpha -subunit in mediating N-type inactivation in the fKv1.4Delta N channel (37) is virtually identical to that established by the landmark studies of Hoshi et al. (21) in Shaker K+ channels. The NH2-terminal domain from the Kvbeta 1.2 subunit also accelerates C-type inactivation in fKv1.4Delta N (33). The NH2 terminus of the Kvbeta 1.2 subunit has a lower affinity for the binding site and more rapid binding kinetics to the inner vestibule so the NH2-terminal domain from Kv1.2 subunit functions more like a rapid open channel blocker such as quinidine (see later in text) (33, 39). This has been studied in Kv1.5 channels by Uebele et al. (41) for the Kvbeta 1.3 subunit and Kv1.5 combination. Kvbeta 1.3 also confers a voltage-dependent, partial inactivation (tau  = 5.76 ± 0.14 ms at +50 mV) and an enhanced slow (possibly C-type) inactivation. In this channel combination, mutation of V512A (which is homologous to V561A in Kv1.4) did not affect the rapid component of Kvbeta 1.3-mediated inactivation, whereas a mutation at the external mouth of the pore (R485Y, equivalent to our K532Y mutation) increased the extent of fast inactivation while preventing the enhancement of slow inactivation. These studies suggest that NH2-terminal binding is allosterically linked to the external pore for a variety of Kv1 channel complexes and may be a critical determinant of many key properties of channel gating.

The demonstration of physical coupling between intracellular and extracellular domains associated with C-type inactivation supports the idea that the Allosteric Hypothesis is physiologically significant. Unquestionably, permeant ion concentrations also play an important role (31). Our experiment with [K+]i substitution used high [K+]o to saturate an external site. This helps eliminate the role of this external site in mediating the increase in the inactivation rate observed in these experiments. However, several previous studies examining the effects of changes in permeant ionic species on different sides of the membrane suggested that there may be additional permeant ion binding sites within the channel (12, 13, 16, 45, 46). Removal of [K+]i may be mediating its effects through changes in the occupancy of such sites. The nature and exact location of such sites remain unknown.

Permeant ions can exert a strong effect on gating transitions such as activation, open probability, channel dwell time, and inactivation (19). In the KcsA channel, intracellular ion binding can change the conformation of the channel at physically distant locations (30, 35). The KcsA channel pore is quite narrow, even in domains outside the selectivity filter (11). Water in such narrow pores is likely to have considerable structure, and the presence of hydrated ions in this small space may affect local protein-water interactions (23). Thus, even if a specific binding site does not exist, this is a potential mechanism by which the concentration or species of flowing ions can alter the stability of different channel conformations.

Figure 7 represents a projection of the fKv1.4 sequence onto the KcsA crystal structure (11) and shows the regions that have been altered or explored in this paper (V561, K532, and H508). Clearly, these sites are physically remote from one another and from the permeation pathway. The insensitivity of the K532 and H508 mutant channels to pHo indicates there must be some interaction between these two sites, but because of the high energy of solvation, it is unlikely that this interaction is electrostatic. It is also unlikely that there is an electrostatic interaction between the charge on H508 at the extracellular side of the membrane and the activity of the positively charged NH2-terminal domain binding to the intracellular side of the channel: given the high dielectric constant of water, it is not energetically feasible. Furthermore, acidosis speeds N-type inactivation, whereas positive charge on H508 would repel the NH2 terminal, thereby slowing inactivation. In addition, electrostatic interactions do not seem likely with a distant and uncharged valine or alanine at position 561. The mutation of a valine to an alanine does not add any additional charge that would contribute an electrostatic component to binding of K+ at extracellular sites. The most likely mechanism is that transmembrane effects are transduced through S6 and possibly other domains, in a process somewhat analogous to activation of the KcsA channel by intracellular protons (10).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 7.   Projection of fKv1.4 onto the crystal structure of KcsA. alpha -Helices are shown as solid red tubes and connecting loops as red ribbons. A: intracellular view; B: side view; C: extracellular view. Turns, such as proline hinges are dark blue. Major difference between fKv1.4 and the KcsA channels is the break in the rigid alpha -helical structure near the intracellular mouth of the channel due to the close proximity of two prolines. Green spheres near this "proline hinge" represent the site of the beta -carbon of V561 in fKv1.4. This site modulates the properties of C-type inactivation, including the [K+]o dependence. Yellow spheres are on the beta -carbon of H508, which modulates the pH sensitivity of N- and C-type inactivation in fKv1.4. Blue spheres are on the beta -carbon of K532, an extracellular site that modulates extracellular TEA binding and C-type inactivation. They are thought to be involved in closure of the extracellular face of the channel.

In summary, our results demonstrate a strong coupling of intracellular domains and extracellular domains associated with S6 and the flanking regions surrounding the extracellular mouth of the pore. The most striking change seen in the V561A mutation was that the [K+]o sensitivity of C-type inactivation was reversed, with inactivation becoming faster with increasing [K+]o. This qualitative behavior is similar to that observed for the Kv4 family of channels (25) and suggests that the mechanism(s) of inactivation between these two channels may be closely related, despite the disparities in biophysical properties. C-type inactivation-like mechanisms are also present in more distantly related channels, such as human ether-à-go-go-related gene (42, 43). In all cases, involvement of mutations on S6 have been noted to have a strong modulatory effect on function, despite being relatively remote from the mouth of the putative extracellular pore domain. Furthermore, it seems that C-type inactivation may have both an extracellular and intracellular "gate" similar to that proposed for activation of the KcsA channel. Understanding the coupling between these regions will enhance our understanding of the time and use dependence of many antiarrhythmic drugs.


    ACKNOWLEDGEMENTS

We thank Dr. Harold Strauss for useful advice and suggestions.


    FOOTNOTES

This study was supported in part by National Heart, Lung, and Blood Institute Grant R01 HL-59526-01, National Science Foundation Knowledge and Distributed Intelligence Grant DBI-9873173, and an Established Investigator Award from the American Heart Association.

Address for reprint requests and other correspondence: R. L. Rasmusson, Dept. of Physiology and Biophysics, 124 Sherman Hall, State Univ. of NY at Buffalo, Buffalo, NY 14214.

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

First published August 29, 2002;10.1152/ajpheart.00392.2002

Received 6 May 2002; accepted in final form 23 August 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Adelman, JP, Bond CT, Pessia M, and Maylie J. Episodic ataxia results from voltage-dependent potassium channels with altered functions. Neuron 15: 1449-1454, 1995.

2.   Armstrong, CM. Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons. J Gen Physiol 58: 413-437, 1971.

3.   Barry, DM, and Nerbonne JM. Myocardial potassium channels: electrophysiological and molecular diversity (Review). Annu Rev Physiol 58: 363-394, 1996.

4.   Baukrowitz, T, and Yellen G. Modulation of K+ current by frequency and external [K+]: a tale of two inactivation mechanisms. Neuron 15: 951-960, 1995.

5.   Boland, LM, Price DL, and Jackson KA. Episodic ataxia/myokymia mutations functionally expressed in the Shaker potassium channel. Neuroscience 91: 1557-1564, 1999.

6.   Busch, AE, Hurst RS, North RA, Adelman JP, and Kavanaugh MP. Current inactivation involves a histidine residue in the pore of the rat lymphocyte potassium channel RGK5. Biochem Biophys Res Commun 179: 1384-1390, 1991.

7.   Choi, KL, Aldrich RW, and Yellen G. Tetraethylammonium blockade distinguishes two inactivation mechanisms in voltage-activated K+ channels. Proc Natl Acad Sci USA 88: 5092-5095, 1991.

8.   Claydon, TW, Boyett MR, Sivaprasadarao A, Ishii K, Owen JM, O'Beirne HA, Leach R, Komukai K, and Orchard CH. Inhibition of the K+ channel kv1.4 by acidosis: protonation of an extracellular histidine slows the recovery from N-type inactivation. J Physiol 526: 253-264, 2000.

9.   Comer, MB, Campbell DL, Rasmusson RL, Lamson DR, Morales MJ, Zhang Y, and Strauss HC. Cloning and characterization of an Ito-like potassium channel from ferret ventricle. Am J Physiol Heart Circ Physiol 267: H1383-H1395, 1994.

10.   Cuello, LG, Romero JG, Cortes DM, and Perozo E. pH-dependent gating in the Streptomyces lividans K+ channel. Biochemistry 37: 3229-3236, 1998.

11.   Doyle, DA, Morais CJ, Pfuetzner RA, Kuo A, Gulbis JM, Cohen SL, Chait BT, and MacKinnon R. The structure of the potassium channel: molecular basis of K+ conduction and selectivity (see Comments). Science 280: 69-77, 1998.

12.   Fan, JS, Jiang M, Dun W, McDonald TV, and Tseng GN. Effects of outer mouth mutations on hERG channel function: a comparison with similar mutations in the Shaker channel. Biophys J 76: 3128-3140, 1999.

13.   Fedida, D, Maruoka ND, and Lin S. Modulation of slow inactivation in human cardiac Kv1.5 channels by extra- and intracellular permeant cations. J Physiol 515: 315-329, 1999.

14.   Ficker, E, Jarolimek W, Kiehn J, Baumann A, and Brown AM. Molecular determinants of dofetilide block of HERG K+ channels. Circ Res 82: 386-395, 1998.

15.   Gidh-Jain, M, Huang B, Jain P, and El Sherif N. Differential expression of voltage-gated K+ channel genes in left ventricular remodeled myocardium after experimental myocardial infarction. Circ Res 79: 669-675, 1996.

16.   Grigoriev, NG, Spafford JD, and Spencer AN. Residues in a jellyfish Shaker-like channel involved in modulation by external potassium. J Neurophysiol 82: 1740-1747, 1999.

17.   Hilgemann, DW. Regulation and deregulation of cardiac Na+-Ca2+ exchange in giant excised sarcolemmal membrane patches. Nature 344: 242-245, 1990.

19.   Hille, B. Ion Channels of Excitable Membranes. Sunderland, MA: Sinauer, 2001.

20.   Holmgren, M, Jurman ME, and Yellen G. N-type inactivation and the S4-S5 region of the Shaker K+ channel. J Gen Physiol 108: 195-206, 1996.

21.   Hoshi, T, Zagotta WN, and Aldrich RW. Biophysical and molecular mechanisms of Shaker potassium channel inactivation (see Comments). Science 250: 533-538, 1990.

22.   Hoshi, T, Zagotta WN, and Aldrich RW. Two types of inactivation in Shaker K+ channels: effects of alterations in the carboxy-terminal region. Neuron 7: 547-556, 1991.

23.   Hummer, G, Rasaiah JC, and Noworyta JP. Water conduction through the hydrophobic channel of a carbon nanotube (see Comments). Nature 414: 188-190, 2001.

24.   Isacoff, EY, Jan YN, and Jan LY. Putative receptor for the cytoplasmic inactivation gate in the Shaker K+ channel. Nature 353: 86-90, 1991.

25.   Jerng, HH, and Covarrubias M. K+ channel inactivation mediated by the concerted action of the cytoplasmic N- and C-terminal domains. Biophys J 72: 163-174, 1997.

26.   Kaprielian, R, Wickenden AD, Kassiri Z, Parker TG, Liu PP, and Backx PH. Relationship between K+ channel down-regulation and [Ca2+]i in rat ventricular myocytes following myocardial infarction. J Physiol 517: 229-245, 1999.

27.   Lee, JK, Nishiyama A, Kambe F, Seo H, Takeuchi S, Kamiya K, Kodama I, and Toyama J. Downregulation of voltage-gated K+ channels in rat heart with right ventricular hypertrophy. Am J Physiol Heart Circ Physiol 277: H1725-H1731, 1999.

28.   Lipkind, GM, Hanck DA, and Fozzard HA. A structural motif for the voltage-gated potassium channel pore. Proc Natl Acad Sci USA 92: 9215-9219, 1995.

29.   Liu, Y, Jurman ME, and Yellen G. Dynamic rearrangement of the outer mouth of a K+ channel during gating. Neuron 16: 859-867, 1996.

30.   Liu, YS, Sompornpisut P, and Perozo E. Structure of the KcsA channel intracellular gate in the open state. Nat Struct Biol 8: 883-887, 2001.

31.   Lopez-Barneo, J, Hoshi T, Heinemann SH, and Aldrich RW. Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels. Receptors Channels 1: 61-71, 1993.

32.   Lopez, GA, Jan YN, and Jan LY. Evidence that the S6 segment of the Shaker voltage-gated K+ channel comprises part of the pore. Nature 367: 179-182, 1994.

33.   Morales, MJ, Wee JO, Wang S, Strauss HC, and Rasmusson RL. The N-terminal domain of a K+ channel beta -subunit increases the rate of C-type inactivation from the cytoplasmic side of the channel. Proc Natl Acad Sci USA 93: 15119-15123, 1996.

34.   Nishiyama, A, Ishii DN, Backx PH, Pulford BE, Birks BR, and Tamkun MM. Altered K+ channel gene expression in diabetic rat ventricle: isoform switching between Kv4.2 and Kv14. Am J Physiol Heart Circ Physiol 281: H1800-H1807, 2001.

35.   Perozo, E, Cortes DM, and Cuello LG. Structural rearrangements underlying K+-channel activation gating (see Comments). Science 285: 73-78, 1999.

36.   Pongs, O. Molecular biology of voltage-dependent potassium channels (Review). Physiol Rev 72: S69-S88, 1992.

37.   Rasmusson, RL, Morales MJ, Castellino RC, Zhang Y, Campbell DL, and Strauss HC. C-type inactivation controls recovery in a fast inactivating cardiac K+ channel (Kv1.4) expressed in Xenopus oocytes. J Physiol 489: 709-721, 1995.

38.   Rasmusson, RL, Morales MJ, Wang S, Liu S, Campbell DL, Brahmajothi MV, and Strauss HC. Inactivation of voltage-gated cardiac K+ channels (Review). Circ Res 82: 739-750, 1998.

39.   Rasmusson, RL, Wang S, Castellino RC, Morales MJ, and Strauss HC. The beta subunit, Kv beta -1.2, acts as a rapid open channel blocker of NH2-terminal deleted Kv14 alpha -subunits. Adv Exp Med Biol 430: 29-37, 1997.

40.   Snyders, DJ, and Chaudhary A. High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol Pharmacol 49: 949-955, 1996.

41.   Uebele, VN, England SK, Gallagher DJ, Snyders DJ, Bennett PB, and Tamkun MM. Distinct domains of the voltage-gated K+ channel Kvbeta 1.3 beta -subunit affect voltage-dependent gating. Am J Physiol Cell Physiol 274: C1485-C1495, 1998.

42.   Wang, S, Morales MJ, Liu S, Strauss HC, and Rasmusson RL. Time, voltage and ionic concentration dependence of rectification of herg expressed in Xenopus oocytes. FEBS Lett 389: 167-173, 1996.

43.   Wang, S, Morales MJ, Liu S, Strauss HC, and Rasmusson RL. Modulation of HERG affinity for E-4031 by [K+]o and C-type inactivation. FEBS Lett 417: 43-47, 1997.

44.  Wang S, Morales MJ, Qu Y, Bett GCL, Strauss HC, and Rasmusson RL. Kv1.4 channel block by quinidine: evidence for a drug-induced allosteric effect. J Physiol. In press.

45.   Wang, Z, Zhang X, and Fedida D. Gating current studies reveal both intra- and extracellular cation modulation of K+ channel deactivation. J Physiol 515: 331-339, 1999.

46.   Wang, Z, Zhang X, and Fedida D. Regulation of transient Na+ conductance by intra- and extracellular K+ in the human delayed rectifier K+ channel Kv1.5. J Physiol 523: 575-591, 2000.

47.   Wissmann, R, Baukrowitz T, Kalbacher H, Kalbitzer HR, Ruppersberg JP, Pongs O, Antz C, and Fakler B. NMR structure and functional characteristics of the hydrophilic N terminus of the potassium channel beta-subunit Kvbeta1.1. J Biol Chem 274: 35521-35525, 1999.

48.   Yellen, G, Sodickson D, Chen TY, and Jurman ME. An engineered cysteine in the external mouth of a K+ channel allows inactivation to be modulated by metal binding. Biophys J 66: 1068-1075, 1994.

49.   Zagotta, WN, Hoshi T, and Aldrich RW. Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB (see Comments). Science 250: 568-571, 1990.

50.   Zhou, M, Morais-Cabral JH, Mann S, and MacKinnon R. Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors (see Comments). Nature 411: 657-661, 2001.


Am J Physiol Heart Circ Physiol 284(1):H71-H80
0363-6135/03 $5.00 Copyright © 2003 the American Physiological Society



This article has been cited by other articles:


Home page
Biophys. JHome page
G. Panaghie, K. Purtell, K.-K. Tai, and G. W. Abbott
Voltage-Dependent C-Type Inactivation in a Constitutively Open K+ Channel
Biophys. J., September 15, 2008; 95(6): 2759 - 2778.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. C. L. Bett and R. L. Rasmusson
Modification of K+ channel-drug interactions by ancillary subunits
J. Physiol., February 15, 2008; 586(4): 929 - 950.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. Imbrici, M. C. D'Adamo, A. Cusimano, and M. Pessia
Episodic ataxia type 1 mutation F184C alters Zn2+-induced modulation of the human K+ channel Kv1.4-Kv1.1/Kvbeta1.1
Am J Physiol Cell Physiol, February 1, 2007; 292(2): C778 - C787.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. W. Putnam, J. A. Filosa, and N. A. Ritucci
Cellular mechanisms involved in CO2 and acid signaling in chemosensitive neurons
Am J Physiol Cell Physiol, December 1, 2004; 287(6): C1493 - C1526.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Somodi, Z. Varga, P. Hajdu, J. G. Starkus, D. I. Levy, R. Gaspar, and G. Panyi
pH-dependent modulation of Kv1.3 inactivation: role of His399
Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1067 - C1076.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
H. Sackin, L.G. Palmer, and M. Krambis
Potassium-Dependent Slow Inactivation of Kir1.1 (ROMK) Channels
Biophys. J., April 1, 2004; 86(4): 2145 - 2155.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/1/H71    most recent
00392.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed